Detalhe da pesquisa
1.
Evaluation of naturally acquired immune responses against novel pre-erythrocytic Plasmodium vivax proteins in a low endemic malaria population located in the Peruvian Amazon Basin.
Malar J
; 23(1): 163, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38783317
2.
Monoclonal antibodies for malaria prevention.
Mol Ther
; 30(5): 1810-1821, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395399
3.
ELQ-331 as a prototype for extremely durable chemoprotection against malaria.
Malar J
; 18(1): 291, 2019 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31455339
4.
Anti-TRAP/SSP2 monoclonal antibodies can inhibit sporozoite infection and may enhance protection of anti-CSP monoclonal antibodies.
NPJ Vaccines
; 7(1): 58, 2022 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618791
5.
Creation and preclinical evaluation of genetically attenuated malaria parasites arresting growth late in the liver.
NPJ Vaccines
; 7(1): 139, 2022 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36333336
6.
Platelet derived growth factor receptor ß (PDGFRß) is a host receptor for the human malaria parasite adhesin TRAP.
Sci Rep
; 11(1): 11328, 2021 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34059712
7.
Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development.
Front Cell Infect Microbiol
; 10: 591046, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33392104
8.
Innate immunity limits protective adaptive immune responses against pre-erythrocytic malaria parasites.
Nat Commun
; 10(1): 3950, 2019 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31477704